Neal, J., Lim, F. L., Fang, B., Torres Lozada, P., Santoro, A., Gonzalez-Cao, M., & FELIP, E. (2024). Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study.

Neal, Joel, Farah Louise Lim, Bruno Fang, Patricia Torres Lozada, Armando Santoro, Maria Gonzalez-Cao, and ENRIQUETA FELIP. Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study. 2024.

Neal, Joel, et al. Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study. 2024.